USFDA concludes inspection at Torrent Pharmaceuticals’ Gujarat manufacturing facility

29 Sep 2022 Evaluate

United States Food and Drug Administration (USFDA) has concluded inspection at Torrent Pharmaceuticals’ Indrad, Gujarat manufacturing facility. The USFDA inspected facility from September 19, 2022 to September 28, 2022. At the end of the inspection, the company have been issued a ‘Form 483’ with 3 observations. None of these observations were related to data integrity.

Torrent Pharmaceuticals is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3950.00 23.05 (0.59%)
27-Jan-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.90
Dr. Reddys Lab 1239.05
Cipla 1305.20
Zydus Lifesciences 890.75
Lupin 2140.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×